Clinical trial
Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome
NCT00199446 · Kyowa Kirin, Inc., Industry · Completed
Key facts
| NCT number | NCT00199446 |
|---|---|
| Title | Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome |
| Official title | A Phase 2, Double-blind, Placebo-controlled, Randomized, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of 40mg/Day KW-6002 (Istradefylline) in Subjects With Restless Legs Syndrome |
| Lead sponsor | Kyowa Kirin, Inc., Industry |
| Collaborators | Kyowa Kirin Co., Ltd. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sleep Disorder, Restless Legs Syndrome |
| Intervention type | Drug |
| Interventions | Istradefylline (KW-6002) |
| Enrollment | 160 |
| Start date | Jul 1, 2005 |
| Primary completion | Aug 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 25, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: